T. cruzi-induced Protective and Pathologic CD4 Responses
T. cruzi-induced Protective and Pathologic CD4 Responses
批准号:
6593762
负责人:
STUART J KAHN
金额:
$24.83万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2005-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objectives of this research
are to understand the mechanisms of chronic inflammatory diseases. Infections
initiate or perpetuate many chronic inflammatory diseases. Trypanosoma cruzi
infection of mice is an excellent system to investigate infection-induced
chronic inflammation. During T. cruzi infection of mammals the CD4 T cell
response is critical in controlling the parasite and in generating the chronic
inflammation. The T. cruzi antigens of the CD4 response have been unknown
limiting further investigations.
The T. cruzi trans-sialidase superfamily simultaneously expresses a large
number of variant epitopes. The effect of these variant epitopes on the T cell
response is unknown. During T. cruzi infection an epitope, epitope 1, of the
trans-sialidase superfamily protein SA85-.1, appears to stimulate a large CD4
response. This project investigates this response's contribution in controlling
the parasite and causing the ensuing chronic inflammation. Cellular immunology
and molecular biology techniques will be used to develop epitope 1- specific T
cell clones and TCR transgenic mice. During T. cruzi infection, these T cells
will be used to analyze: the size and specificity of the SA85-1.1 protein and
epitope 1 responses; the mechanisms used by epitope 1 specific T cell clones to
protect, and the clones' ability to cause chronic inflammation; and the naive
epitope 1 specific CD4 T cell response and these cells' ability to control T.
cruzi and cause chronic inflammation. Completion of these aims will clarify the
relationship of T. cruzi-induced protective and inflammatory T cell responses,
and will provide insight into infection-induced T cell responses and chronic
inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase 1 Randomized Single Oral Dose Four Period Cross-Over Study Investigating Omnitram Dose Proportionality and Food Effect in Normal Human Subjects
-
批准号:10372803
-
项目类别:
-
资助金额:$8.02万
-
财政年份:2019
-
负责人:STUART J KAHN
-
依托单位:
A Phase 1 Randomized Single Oral Dose Four Period Cross-Over Study Investigating Omnitram Dose Proportionality and Food Effect in Normal Human Subjects
-
批准号:10029002
-
项目类别:
-
资助金额:$120.48万
-
财政年份:2019
-
负责人:STUART J KAHN
-
依托单位:
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
-
批准号:9789451
-
项目类别:
-
资助金额:$142.44万
-
财政年份:2018
-
负责人:STUART J KAHN
-
依托单位:
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
-
批准号:9348033
-
项目类别:
-
资助金额:$62.1万
-
财政年份:2017
-
负责人:STUART J KAHN
-
依托单位:
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
-
批准号:10189528
-
项目类别:
-
资助金额:$65.14万
-
财政年份:2017
-
负责人:STUART J KAHN
-
依托单位:
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
-
批准号:9755385
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2017
-
负责人:STUART J KAHN
-
依托单位:
Phase II clinical evaluation of Omnitram in neuropathic pain
-
批准号:8981655
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:STUART J KAHN
-
依托单位:
Phase II clinical evaluation of Omnitram in neuropathic pain
-
批准号:9317459
-
项目类别:
-
资助金额:$65.72万
-
财政年份:2015
-
负责人:STUART J KAHN
-
依托单位:
Efficacy and resistance mechanisms of LD-aminopterin in psoriasis
-
批准号:8792437
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:STUART J KAHN
-
依托单位:
Efficacy and resistance mechanisms of LD-aminopterin in psoriasis
-
批准号:9188625
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2014
-
负责人:STUART J KAHN
-
依托单位:
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers
-
批准号:8713969
-
项目类别:
-
资助金额:$58.31万
-
财政年份:2010
-
负责人:STUART J KAHN
-
依托单位:
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers
-
批准号:8315819
-
项目类别:
-
资助金额:$57.41万
-
财政年份:2010
-
负责人:STUART J KAHN
-
依托单位:
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers
-
批准号:8517634
-
项目类别:
-
资助金额:$93.35万
-
财政年份:2010
-
负责人:STUART J KAHN
-
依托单位:
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers
-
批准号:7746973
-
项目类别:
-
资助金额:$64.95万
-
财政年份:2010
-
负责人:STUART J KAHN
-
依托单位:
The Treatment of Methotrexate Resistant Rheumatoid Arthritis With Aminopterin
-
批准号:7746965
-
项目类别:
-
资助金额:$51.86万
-
财政年份:2009
-
负责人:STUART J KAHN
-
依托单位:
Aminopterin for the Treatment of Severe Recalcitrant Atopic Dermatitis
-
批准号:7538987
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2008
-
负责人:STUART J KAHN
-
依托单位:
Aminopterin for the Treatment of Severe Recalcitrant Atopic Dermatitis
-
批准号:7683762
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2008
-
负责人:STUART J KAHN
-
依托单位:
The Function of NKT Cells During T Cruzi Infection
-
批准号:6610985
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2001
-
负责人:STUART J KAHN
-
依托单位:
T. cruzi-induced Protective and Pathologic CD4 Responses
-
批准号:6511407
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2001
-
负责人:STUART J KAHN
-
依托单位:
T. cruzi-induced Protective and Pathologic CD4 Responses
-
批准号:6770152
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2001
-
负责人:STUART J KAHN
-
依托单位:
海外基金